Human malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells

Rosanna Mezzapelle, Eltjona Rrapaj, Elena Gatti, Chiara Ceriotti, Francesco De Marchis, Alessandro Preti, Antonello E. Spinelli, Laura Perani, Massimo Venturini, Silvia Valtorta, Rosa Maria Moresco, Lorenza Pecciarini, Claudio Doglioni, Michela Frenquelli, Luca Crippa, Camilla Recordati, Eugenio Scanziani, Hilda De Vries, Anton Berns, Roberta FrapolliRenzo Boldorini, Maurizio D'Incalci, Marco E. Bianchi, Massimo P. Crippa

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

Malignant Mesothelioma is a highly aggressive cancer, which is difficult to diagnose and treat. Here we describe the molecular, cellular and morphological characterization of a syngeneic system consisting of murine AB1, AB12 and AB22 mesothelioma cells injected in immunocompetent BALB/c mice, which allows the study of the interplay of tumor cells with the immune system. Murine mesothelioma cells, like human ones, respond to exogenous High Mobility Group Box 1 protein, a Damage-Associated Molecular Pattern that acts as a chemoattractant for leukocytes and as a proinflammatory mediator. The tumors derived from AB cells are morphologically and histologically similar to human MM tumors, and respond to treatments used for MM patients. Our system largely recapitulates human mesothelioma, and we advocate its use for the study of MM development and treatment.

Lingua originaleInglese
Numero di articolo22850
RivistaScientific Reports
Volume6
DOI
Stato di pubblicazionePubblicato - 10 mar 2016
Pubblicato esternamente

Fingerprint

Entra nei temi di ricerca di 'Human malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells'. Insieme formano una fingerprint unica.

Cita questo